Bold zebrafish (Danio rerio) express higher levels of delta opioid and dopamine D2 receptors in the brain compared to shy fish.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 22 12 2017
revised: 28 05 2018
accepted: 19 06 2018
pubmed: 24 6 2018
medline: 4 4 2019
entrez: 24 6 2018
Statut: ppublish

Résumé

Individual variation in coping with environmental challenges is a well-known phenomenon across vertebrates, including teleost fish. Dopamine is the major transmitter in the brain reward networks, and important for motivational processes and stress coping. Functions of the endogenous opioid system are not well studied in teleosts. However, in mammals the activity in the brain reward networks is regulated by the endogenous opioid system. This study aimed at investigating if there was a correlation between risk-taking behavior and the expression of dopamine and opioid receptors in the zebrafish (Danio rerio) brain. Risk-taking behavior was assessed in a novel tank diving test, and the most extreme high risk taking, i.e. bold, and low risk taking, i.e. shy, fish were sampled for qPCR analysis of whole brain gene expression. The expression analysis showed a significantly higher expression of the dopamine D2 receptors (drd2a and drd2b) and the delta opioid receptor (DOR; oprd1b) in bold compared to shy fish. Besides reward and reinforcing properties, DORs are also involved in emotional responses. Dopamine D2 receptors are believed to be important for active stress coping in rodents, and taken together the results of the current study suggest similar functions in zebrafish. However, additional experiments are required to clarify how dopamine and opioid receptor activation affect behavior and stress coping in this species.

Identifiants

pubmed: 29935279
pii: S0166-4328(17)32048-X
doi: 10.1016/j.bbr.2018.06.017
pii:
doi:

Substances chimiques

Receptors, Dopamine D2 0
Receptors, Opioid, delta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

927-934

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Per-Ove Thörnqvist (PO)

Department of Neuroscience, Physiology Unit, Biomedical Centre (BMC), Uppsala University, Box 593, SE-75124 Uppsala, Sweden. Electronic address: per-ove.thornqvist@neuro.uu.se.

Sarah McCarrick (S)

Unit of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden.

Maja Ericsson (M)

Department of Neuroscience, Physiology Unit, Biomedical Centre (BMC), Uppsala University, Box 593, SE-75124 Uppsala, Sweden.

Erika Roman (E)

Department of Pharmaceutical Biosciences, Neuropharmacology, Addiction and Behavior Unit, Biomedical Centre (BMC), Uppsala University, Box 591, SE-75124 Uppsala, Sweden.

Svante Winberg (S)

Department of Neuroscience, Physiology Unit, Biomedical Centre (BMC), Uppsala University, Box 593, SE-75124 Uppsala, Sweden.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH